VATIVIO®


Film-coated tablets
scheduling status
S4
registration number
46/26/0367, 46/26/0368
What VATIVIO® contains
VATIVIO® FC: Each film-coated tablet contains 119,5 mg imatinib mesilate equivalent to 100 mg imatinib base. VATIVIO® 400: Each film-coated tablet contains 478,00 mg imatinib mesilate equivalent to 400 imatinib base.
other ingredients
Tablet content: Cellulose microcrystalline, Crospovidone, Hypromellose, Magnesium stearate, Silica colloidal anhydrous. Coating content: Iron oxide, red (E 172), Iron oxide, yellow (E 172), Hypromellose, Polyethylene Glycol, Talc.
Therapeutic classification
BCR-ABL tyrosine kinase inhibitor, ATC code: L01EA01.
© 2026 SAHPRA. ALL RIGHTS RESERVED